Microbiotica Announces First Patient Dosed in its Phase 1b Trial ...

Crestone Releases Encouraging Phase 2 Trial Results for CRS3123 ...

("Crestone") announced promising initial results from its Phase 2 clinical trial of CRS3123 in patients with Clostridioides difficile infection ...

The Ins and Outs of Fecal Microbiota Transplantation Administration

Rebiotix announces first patient enrolled in phase 3 clinical trial of RBX2660 for the prevention of recurrent clostridium difficile infection.

News | Page 5 of 28 - Seventure Partners

Enterome announces sustained positive clinical outcomes with EO2401 · Galecto Completes Dosing in 52-Week Phase 2b GALACTIC-1 Trial of GB0139 in Idiopathic ...

Federation Bio Administers First Dose in Phase 1 Clinical Trial ...

Federation Bio, a biotechnology company pioneering bacterial cell therapies, announced that investigators have administered the first dose ...

Vedanta Biosciences Announces First Patient Dosed in Phase 2 ...

VE202 is an orally administered, rationally-defined bacterial consortium candidate for the treatment of ulcerative colitis.

EnteroBiotix Announces Positive Ph1b Clinical Results of EBX-102 ...

... announced positive results from its Phase 1b IMPuLCE study evaluating EBX-102 in patients with liver cirrhosis. EnteroBiotix's first-in-human ...

VTP-300, Nivolumab Combination Shows Promise for Functional ...

New phase 2b data from the ongoing HBV003 clinical trial demonstrate the ability of VTP-300 combined with low-dose nivolumab to stimulate ...

EnteroBiotix reports positive results from phase 1b IMPuLCE study ...

... announced positive results from its phase 1b IMPuLCE study evaluating EBX-102 in patients with liver cirrhosis. EnteroBiotix's first-in-human ...

Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 ...

Zhiyi Biotech has announced the initiation of the U.S. Phase 1 clinical trial for their innovative product SK10, which is aimed at ...

Microbiome Therapeutics - Commercialization Opportunities and ...

As an example, in its Phase 1b study, Siolta Therapeutics focused on ... First microbiome-based drug clears phase III, in clinical trial turnaround.

Microbiotica's Microbiome Medicines in Melanoma and Ulcerative ...

announce that it has received regulatory approvals to initiate clinical studies for its first two programmes in advanced melanoma (. ) and ...

EnteroBiotix Completes Phase 2 Study Recruitment of

The Company recently announced positive results in a Phase 1b clinical study of its full-spectrum product EBX-102 in patients with liver ...

Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of ...

Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection ( ...

Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 ...

Zhiyi Biotech announced that the first three subjects have been dosed in the US Phase 1 clinical trial of SK10, an innovative heat-killed Bacteroides fragilis ...

First Bladder Cancer Patient Dosed with Commercially Available ...

It is the first and only FDA-approved intravesical gene therapy for adults with NMIBC who no longer respond to standard therapy.

Microbiotica 's Post - LinkedIn

A major milestone as we can confirm that the first patient has been dosed in our international Phase 1b MELODY-1 trial of MB097, ...

Bloom Science Completes Enrollment in Phase 1 Trial of BL-001, a ...

"The initial dosing and completion of enrollment of our Phase 1 clinical trial ... the potential to provide patients with the same ...

Positive Results From Pharmacokinetics Study of AD04 for the ...

... phase 3 trial protocol, including evaluating the optimal dosing regimen to maximize the efficacy and safety of AD04 in patients with AUD.

Gut check: The FDA approves microbiome-based therapies, with ...

VOWST™ is the first fecal microbiota product approved by the FDA for oral administration. Seres announced that they plan to sell VOWST™ in ...

Drugs that made headlines in 2013 | Nature Medicine

Yet the drug actually succeeded in prolonging life in a lower-profile phase 3 trial in patients with gastric cancer. In October, The FDA decided ...